 fluorouracil recombin human interferon treatment metastat chemotherapy-refractori urotheli tumor thirti patient advanc metastat chemotherapy-refractori urotheli tumor combin fluorouracil recombin human interferon site metastas present studi patient median eastern cooper oncolog group perform statu rang patient primari methotrexate/cisplatin-bas chemotherapi nine confid interv patient partial respons mean durat respons month median month rang month patient partial respons month durat control residu diseas radiat surgic excis disease-fre addit period month data combin recombin human interferon synergist clinic signific treatment urotheli tumor respons rate combin drug agent addit confirmatori trial signific find